Michelle Sweidan

Learn More
OBJECTIVE To explore Australian general practitioners' and pharmacists' preferences in relation to content, format and usability of drug interaction alerts in prescribing and dispensing software. DESIGN, PARTICIPANTS AND SETTING Surveys that sought opinions on drug interaction decision support were mailed to a random sample of GPs and community(More)
BACKGROUND Electronic prescribing is increasingly being used in primary care and in hospitals. Studies on the effects of e-prescribing systems have found evidence for both benefit and harm. The aim of this study was to identify features of e-prescribing software systems that support patient safety and quality of care and that are useful to the clinician and(More)
Would you prescribe a drug without regulatory approval, for which the safety and efficacy are unknown? Unlikely. Would you use a clinical practice guideline that is not endorsed by a peak body, with no accessible evidence for its recommendations and with its authorship unknown? Unlikely. Do you currently use decision support tools in your prescribing(More)
Background: Electronic prescribing is now the norm in many countries. We wished to find out if clinical software systems used by general practitioners in Australia include features (functional capabilities and other characteristics) that facilitate improved patient safety and care, with a focus on quality use of medicines. Methods: Seven clinical software(More)
OBJECTIVE To investigate the quality of drug interaction decision support in selected prescribing and dispensing software systems, and to compare this information with that found in a range of reference sources. DESIGN AND SETTING A comparative study, conducted between June 2006 and February 2007, of the support provided for making decisions about 20(More)
  • 1